300999:SZSEYihai Kerry Arawana Holdings Co. Ltd. Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥31.11
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Yihai Kerry Arawana trades around CNY 31.1, just above its 200‑day SMA of 30.59 and comfortably above the 20‑day SMA of 29.99, indicating a modest upward bias. The RSI sits at 58, well below overbought levels, while the MACD histogram is positive, supporting a bullish technical backdrop. Volume is on an increasing trend, and the stock is positioned midway between a support near 28.4 and resistance around 33.6, offering upside potential of roughly 10% as reflected in the upside/downside estimate. Fundamentally, the company faces challenges: revenue has slipped 4% year‑over‑year, operating margins are thin at 2.7%, and ROE is only 3.2%, while the debt‑to‑equity ratio is high at nearly 90%, suggesting a leveraged balance sheet. The trailing PE of 44× is markedly above the market average, even though the forward PE contracts to about 24×, and the price‑to‑sales ratio of 0.69 hints at a relatively cheap sales multiple. The dividend payout is modest at 0.35% with a low payout ratio of 16%, making the current yield appear sustainable. Risk‑adjusted returns are mixed: a very low beta (≈0.08) points to limited market sensitivity, yet 30‑day volatility exceeds 36%, and the consumer‑defensive sector typically offers stability but is subject to Chinese food‑safety and policy scrutiny. Overall, the stock presents a borderline overvalued profile with a value‑oriented tilt, modest dividend appeal, and a technical environment that favors cautious optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and SMA alignment
- Near‑term resistance at 33.6 limiting upside
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Improving forward PE and sales multiple
- Sustainable dividend payout
- Increasing volume supporting price appreciation
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Weak revenue growth and thin margins
- Elevated debt‑to‑equity ratio
- Stable consumer‑defensive sector backdrop
Key Metrics & Analysis
Financial Health
Revenue Growth-4.00%
Profit Margin1.29%
P/E Ratio43.8
ROE3.17%
Debt/Equity89.70
P/B Ratio1.8
Technical Analysis
TrendNeutral
RSI58.1
SupportCN¥28.40
ResistanceCN¥33.61
MA 20CN¥29.99
MA 50CN¥29.76
MA 200CN¥30.59
MACDBullish
VolumeIncreasing
Fear & Greed Index81.45
Valuation
Target PriceCN¥34.20
Upside/Downside9.93%
GradeOvervalued
TypeValue
Dividend Yield0.35%
Risk Assessment
Beta0.08
Volatility36.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.